Neodent GM X 6mm Engaging Titanium Base, REF: 9007162

FDA Device Recall #Z-1285-2023 — Class II — February 21, 2023

Recall Summary

Recall Number Z-1285-2023
Classification Class II — Moderate risk
Date Initiated February 21, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Preat Corp
Location Santa Maria, CA
Product Type Devices
Quantity 26

Product Description

Neodent GM X 6mm Engaging Titanium Base, REF: 9007162

Reason for Recall

Engaging titanium base contains a dimensional condition that allows vertical movement of the titanium base after the prosthetic screw is torqued to the recommended value, which if undetected and installed on the implant, may lead to abutment/screw fracture, which could result in the abutment/screw/crown being ingested by the patient.

Distribution Pattern

US Nationwide distribution in the states of TX, OR, UT, NY.

Lot / Code Information

UDI: 00842092161326, Lots: 211891 and 211912

Other Recalls from Preat Corp

Recall # Classification Product Date
Z-2514-2025 Class II NobelBiocare Tri-Lobe-compatible WP X 6.0mm Eng... Jun 25, 2025
Z-2107-2025 Class II Preat, Astra EV-compatible 4.2mm Digital Analog... Jun 24, 2025
Z-1987-2025 Class II Biomet 3i Certain-compatible 4.1 mm Milled Ti A... Apr 2, 2025
Z-2687-2024 Class II Multiple Digital Analog Products labeled as: N... Jun 25, 2024
Z-2318-2024 Class II 9006767 Astra EV 4.8mm Milled Titanium Abutment... Apr 10, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.